Identification of novel TMPRSS2 inhibitors for COVID-19 using e-pharmacophore modelling, molecular docking, molecular dynamics and quantum mechanics studies

SARS coronavirus 2 (SARS-CoV-2) has spread rapidly around the world and continues to have a massive global health effect, contributing to an infectious respiratory illness called coronavirus infection-19 (COVID-19). TMPRSS2 is an emerging molecular target that plays a role in the early stages of SAR...

Full description

Bibliographic Details
Main Authors: Abdulrahim A. Alzain, PhD, Fatima A. Elbadwi
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Informatics in Medicine Unlocked
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352914821002331
_version_ 1831569813838757888
author Abdulrahim A. Alzain, PhD
Fatima A. Elbadwi
author_facet Abdulrahim A. Alzain, PhD
Fatima A. Elbadwi
author_sort Abdulrahim A. Alzain, PhD
collection DOAJ
description SARS coronavirus 2 (SARS-CoV-2) has spread rapidly around the world and continues to have a massive global health effect, contributing to an infectious respiratory illness called coronavirus infection-19 (COVID-19). TMPRSS2 is an emerging molecular target that plays a role in the early stages of SARS-CoV-2 infection; hence, inhibiting its activity might be a target for COVID-19. This study aims to use many computational approaches to provide compounds that could be optimized into clinical candidates. As there is no experimentally derived protein information, initially we develop the TMPRSS2 model. Then, we generate a pharmacophore model from TMPRSS2 active site consequently, and the developed models were employed for the screening of one million molecules from the Enamine database. The created model was then screened using e-pharmacophore-based screening, molecular docking, free energy estimation and molecular dynamic simulation. Also, ADMET prediction and density functional theory calculations were performed. Three potential molecules (Z126202570, Z46489368, and Z422255982) exhibited promising stable binding interactions with the target. In conclusion, these findings empower further in vitro and clinical assessment for these compounds as novel anti-COVID19 agents.
first_indexed 2024-12-17T12:40:26Z
format Article
id doaj.art-2a97d1d7426b4c3e8abfee2ba47a4629
institution Directory Open Access Journal
issn 2352-9148
language English
last_indexed 2024-12-17T12:40:26Z
publishDate 2021-01-01
publisher Elsevier
record_format Article
series Informatics in Medicine Unlocked
spelling doaj.art-2a97d1d7426b4c3e8abfee2ba47a46292022-12-21T21:48:02ZengElsevierInformatics in Medicine Unlocked2352-91482021-01-0126100758Identification of novel TMPRSS2 inhibitors for COVID-19 using e-pharmacophore modelling, molecular docking, molecular dynamics and quantum mechanics studiesAbdulrahim A. Alzain, PhD0Fatima A. Elbadwi1Corresponding author. 21111 Barakat Street, Medani, Gezira, Sudan.; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Gezira, Gezira, SudanDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Gezira, Gezira, SudanSARS coronavirus 2 (SARS-CoV-2) has spread rapidly around the world and continues to have a massive global health effect, contributing to an infectious respiratory illness called coronavirus infection-19 (COVID-19). TMPRSS2 is an emerging molecular target that plays a role in the early stages of SARS-CoV-2 infection; hence, inhibiting its activity might be a target for COVID-19. This study aims to use many computational approaches to provide compounds that could be optimized into clinical candidates. As there is no experimentally derived protein information, initially we develop the TMPRSS2 model. Then, we generate a pharmacophore model from TMPRSS2 active site consequently, and the developed models were employed for the screening of one million molecules from the Enamine database. The created model was then screened using e-pharmacophore-based screening, molecular docking, free energy estimation and molecular dynamic simulation. Also, ADMET prediction and density functional theory calculations were performed. Three potential molecules (Z126202570, Z46489368, and Z422255982) exhibited promising stable binding interactions with the target. In conclusion, these findings empower further in vitro and clinical assessment for these compounds as novel anti-COVID19 agents.http://www.sciencedirect.com/science/article/pii/S2352914821002331SARS-CoV-2TMPRSS2Homology modelinge-pharmacophore mapping and screeningDockingMolecular dynamics
spellingShingle Abdulrahim A. Alzain, PhD
Fatima A. Elbadwi
Identification of novel TMPRSS2 inhibitors for COVID-19 using e-pharmacophore modelling, molecular docking, molecular dynamics and quantum mechanics studies
Informatics in Medicine Unlocked
SARS-CoV-2
TMPRSS2
Homology modeling
e-pharmacophore mapping and screening
Docking
Molecular dynamics
title Identification of novel TMPRSS2 inhibitors for COVID-19 using e-pharmacophore modelling, molecular docking, molecular dynamics and quantum mechanics studies
title_full Identification of novel TMPRSS2 inhibitors for COVID-19 using e-pharmacophore modelling, molecular docking, molecular dynamics and quantum mechanics studies
title_fullStr Identification of novel TMPRSS2 inhibitors for COVID-19 using e-pharmacophore modelling, molecular docking, molecular dynamics and quantum mechanics studies
title_full_unstemmed Identification of novel TMPRSS2 inhibitors for COVID-19 using e-pharmacophore modelling, molecular docking, molecular dynamics and quantum mechanics studies
title_short Identification of novel TMPRSS2 inhibitors for COVID-19 using e-pharmacophore modelling, molecular docking, molecular dynamics and quantum mechanics studies
title_sort identification of novel tmprss2 inhibitors for covid 19 using e pharmacophore modelling molecular docking molecular dynamics and quantum mechanics studies
topic SARS-CoV-2
TMPRSS2
Homology modeling
e-pharmacophore mapping and screening
Docking
Molecular dynamics
url http://www.sciencedirect.com/science/article/pii/S2352914821002331
work_keys_str_mv AT abdulrahimaalzainphd identificationofnoveltmprss2inhibitorsforcovid19usingepharmacophoremodellingmoleculardockingmoleculardynamicsandquantummechanicsstudies
AT fatimaaelbadwi identificationofnoveltmprss2inhibitorsforcovid19usingepharmacophoremodellingmoleculardockingmoleculardynamicsandquantummechanicsstudies